Henry Miller

Henry I. Miller, MS, MD, is the Glenn Swogger Distinguished Fellow at the American Council on Science and Health. His research focuses on public policy toward science and technology, encompassing several areas, including pharmaceutical development, genetic engineering, models for regulatory reform and the emergence of new viral diseases.

Dr. Miller served for 15 years at the U.S. Food and Drug Administration (FDA) in several posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone.

Dr. Miller’s work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider’s View; To America’s Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron’s selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Dr. Miller has published extensively in a wide spectrum of scholarly journals and prestigious publications worldwide. He appears regularly on two nationally syndicated radio programs.